Abstract Caspases are a family of proteins important for the elimination of infected cells through the induction of apoptosis as well as the initiation of inflammatory cytokines including IL-1β and IL-18. Morphine exposure to animals and/or cells has been associated with the induction of apoptosis. The most common practices of apoptosis detection have involved removing tissues from animal or humans and the analysis of apoptosis on cells or tissues. These methods can potentially induce spontaneous apoptosis that is unrelated to the actual treatment. The objective of this study was to develop an in vivo detection method for assessing caspase activity induced both by morphine directly and by morphine combined with lipopolysaccharide (LPS)-immune activation. Mice were administered saline, morphine, LPS, or a combination of morphine and LPS. Prior to sacrifice, mice were injected with a polycaspase-specific apoptosis detection probe to detect internal caspase activity in vivo. Results revealed that morphine alone did not directly induce caspase activity. However, morphine significantly enhanced the LPS-induced caspase activity in spleen, thymus, and bone marrow-derived immune cells. The use of a poly-caspase detection probe methodology to label caspase activity in vivo provides a powerful quantitative tool for the in vivo analysis of caspase activity.
Introduction
The opiate morphine is one of the most widely utilized drugs for controlling chronic pain (Portenoy and Lesage 1999) . The use of opiates in humans warrants concern due to their cytotoxic effects, the potential to be addictive, and their potential impact on the immune system. In vitro studies have indicated that morphine induces caspase activity leading to apoptosis in a variety of human and rodent peripheral immune system-related cells (Singhal et al. 1998; Yin et al. 1999) , as well as in embryonic neuronal and glial cultured cells (Hu et al. 2002) . Morphine induces oxidative stress in macrophages, T lymphocytes, and hepatocytes inducing apoptosis via a Fas receptor, promoting the analgesic effects of opiates and manifesting secondary cytolytic effects involved in pain treatment regimens (Payabvash et al. 2006; Wang et al. 2001) .
The apoptotic effects of chronic opioid administration have been studied in multiple in vitro and in vivo models. In selected studies, morphine's induction of apoptosis was associated with an up-regulation of the pro-apoptotic caspase-3 and Bax proteins and the down-regulation of the anti-apoptotic Bcl-2 protein (Mao et al. 2002) . However, others reported that the principal mechanism by which morphine mediated apoptosis is via the Fas/FasL extrinsic pathway signal transduction (Yin et al. 1999; Boronat et al. 2001; Emeterio et al. 2006 ).
Until very recently, the detection of apoptosis required ex vivo harvesting techniques such as DNA fragmentation assays utilizing the terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay (Duan et al. 2003) or extracellular staining by annexin (Liu et al. 2001; Stahelin et al. 1998) . Conventionally, apoptosis detection has required the removal of tissues from their natural environment, thereby depleting the individual cells of required oxygen and nutrients and inducing apoptosis (Malhotra et al. 2001) . In addition, the mechanical manipulation of the tissue physically damages cell membranes leading to increased levels of cellular death through apoptosis as well as necrosis. These increased levels of apoptosis are not distinguishable from the initial apoptotic event caused by the experimental agent leading to the generation of false-positive results.
In vitro methods for the detection of apoptosis have been developed employing fluorogenic/chromogenic caspase probes (Lee et al. 2003; Mizukami et al. 1999) , detecting active caspase enzymes by immunocytochemistry or their specific cleavage products (Li et al. 2000) and mitochondrial potentiometric dye-based assays (Poot et al. 1996; Salvioli et al. 1997 ). More recently, fluorescence-labeled inhibitors of caspases (FLICA) (Amstad et al. 2001; Bedner et al. 2000) probes were generated and employed for the detection of caspases activity in vitro. FLICA reagents employ a cell-permeable probe that covalently binds to active caspases. In vitro apoptotic detection by FLICA reagent demonstrated a strong correlation with TUNEL (r= 0.95; Bedner et al. 2000) .
While in vitro assays have answered many immunological questions leading to a better understanding of cellular death, in vitro assays do not always translate accurately into what is actually happening in vivo. As a means to address specific questions involving apoptosis within an animal, a fluorescent-labeled poly-caspase inhibitor (FLIVO) reagent for detection of apoptosis was previously optimized in vivo (Riol-Blanco et al. 2009; Cursio et al. 2009 Cursio et al. , 2008 Griffin et al. 2007) . FLIVO is an inhibitor of activated caspases which binds to cells undergoing caspase-dependent apoptosis and inhibits the progression of programmed cell death to some extent. This temporary hold on apoptotic cells makes FLIVO a valuable reagent for live detection of apoptotic activity (Smolewski et al. 2002) , allowing researchers to answer the many questions left unanswered due to the lack of in vivo apoptosis detection. The current study used the FLICA probes to detect, in vivo, caspase activity as a consequence of morphine exposure. By employing the cell-permeant probe for in vivo caspase labeling, we were able to circumvent the false-positive results due to tissue manipulation and found that morphine significantly increased lipopolysaccharide (LPS)-induced caspase activity in various tissues.
Materials and methods
Mice C57BL/129 wild-type and opioid receptor mu-knockout mice were housed and cared for under specific pathogenfree conditions in accordance with the University of Minnesota Institutional Animal Care and Use Committee.
Morphine and LPS injection of mice Mice were grouped into placebo, morphine, LPS, or morphine + LPS treatment groups, n=8/group. Morphine was administered via intraperitoneal (IP) injection at a daily dosage of 25 mg/kg, 24 and 48 h prior to sacrifice as previously described (Roy et al. 1999) . Twenty-five micrograms (1 mg/kg) of LPS purified from Escherichia coli, strain 0127B8, was administered intraperitoneally 24 h prior to euthanasia. Saline was used as a placebo control.
In vivo caspase detection Thirty minutes prior to sacrifice, 10 μg of multi-caspase detection probe (FLIVO) (Immunochemistry Technologies, LLC. Bloomington, MN, USA) was administered via tail vein injection at a dosage of 400 μg/kg. FLIVO injection solution was prepared by dissolving the contents of one vial of the carboxyfluorescein-valylalanylaspartic acid-fluoromethyl ketone caspase detection reagent in 50 μL of tissue culture grade DMSO. The FLIVO reagent was further diluted 1:10 in sterile isotonic injection buffer to yield the 1× FLIVO reagent solution. A 100-μL volume of 1× FLIVO caspase detection probe was injected via the tail vein.
Splenocytes and bone marrow preparation Mice were anesthetized with CO 2 followed by cervical dislocation. Spleens were removed and washed three times in 1× PBS buffer solution. Splenocytes were isolated from the spleens as previously described (Lin et al. 2007 ). Spleens were homogenized and strained through a 100-µm pore size cell straining filter to remove connective tissue. Splenocytes were centrifuged at 650×g for 5 min and resuspended in 1 mL deionized H 2 O to lyse remaining red blood cells, washed, and analyzed by flow cytometry. Bone marrow was isolated by removing skin and muscle from hind legs using aseptic technique. Femurs were severed between joints. Bone marrow was flushed by inserting a 25-Ga needle into the cavity and injecting sterile cold phosphatebuffered saline solution containing 2% fetal bovine serum into the cavity to remove the cells (Aldeguer et al. 2002) . Bone marrow wash medium was collected into sterile 50 mL tubes and kept on ice. Residual red blood cells were water-lysed, and the bone marrow contents were immediately analyzed by flow cytometry.
Immunohistochemistry Spleen, liver, thymus, and central nervous system tissues were snap frozen in liquid nitrogen, placed in plastic trays, immersed in OCT, and stored frozen at −80°C. Frozen tissues were subsequently sectioned in low light conditions and mounted on glass slides for fluorescent microscopy. DAPI staining was used to determine cellassociated apoptotic events. Sections were photographed and analyzed by MetaMorph analysis program (Molecular Devices Corporation, Sunnyvale, CA, USA) for apoptosispositive cell counts. Ten sections were analyzed at a magnification of ×60.
Data analysis and statistical analysis Splenocyte and bone marrow apoptosis were analyzed using a FACScaliber at a final concentration of 1×10 6 cells/mL, and the results were analyzed by CellquestPro (Becton Dickinson Immunocytometry System, San Jose, CA, USA). Statistically significance was assessed by two-way ANOVA with ad hoc unpaired Student's t test for analysis between two groups. Differences between data were considered statistically significant at p<0.05.
Results
Although there have been extensive studies involving morphine's immunomodulatory effects on immunity, there still remains controversy regarding morphine's effects on apoptosis-mediated activity. A major reason for this controversy relates to limitation in the methodology to detect apoptosis in cells and tissues. To address the question of morphine's potential modulatory effects on caspase activity, we employed a novel approach to detect apoptosis in vivo.
Synergistic effects of morphine and LPS on the induction of caspase in splenocytes
There are many commercially available assays for the detection of apoptosis, each having particular strengths and weaknesses. The main weakness of current methods is the requirement for ex vivo manipulation of tissues. A cellpermeant fluorescently labeled probe was developed to detect and quantitate apoptosis via caspase activity (Lee et al. 2003) . The present study is the first to use a cellpermeant probe in mice to detect caspase activity in vivo. Thirty minutes post-inoculation, mice were euthanized and splenocytes were immediately purified and analyzed for caspase activity using flow cytometry. The caspase-specific probe labeled caspase activity in vivo rather than ex vivo avoiding false-positive results due to manipulation. Using CellquestPro, a histogram of the various treatment groups was derived and overlaid for analysis (Fig. 1a) . Percentages of cells demonstrating caspase activity were imported into a dot plot (Fig. 1b) and analyzed by ANOVA for statistical significance (p=0.001). The results showed that LPS administration into mice significantly induced caspases compared to placebotreated mice (p=0.03). Co-administration of morphine + LPS significantly increased caspase activity (p=0.01). Morphine alone did not significantly induce caspase activity.
Synergistic effects of morphine and LPS on the induction of caspase in bone marrow
The bone marrow is essential for the generation of progenitor cells, maintaining a constant percentage of competent immune components. To determine whether morphine exposure enhances the effect of LPS in progen- Fig. 1 Administration of morphine significantly increased LPSinduced apoptosis in cells of the immune system. Morphine was administered 24 and 48 h prior to sacrifice at a concentration of 25 mg/kg and LPS was administered 24 h prior to sacrifice. Caspasespecific probes were injected into mice 30 min prior to sacrifice. Splenocytes from placebo, LPS-treated, and morphine + LPS-treated mice were purified and analyzed for apoptotic events. a Splenocytes from placebo, LPS, and LPS + morphine were purified and analyzed by flow cytometry. Using CellquestPro, a histogram of the various groups was overlaid to analyze morphine's effect on LPS-induced apoptosis. Plots are representative of the groups (n=8). b Percentages derived from CellquestPro were plotted in a bar graph. A statistically significant change was determined by p<0.05 itor cells, bone marrow was isolated from the various treatment groups and immediately analyzed by flow cytometry (Fig. 2a) . Percentages of caspase-positive cells were imported into a dot plot (Fig. 2b) and analyzed by ANOVA for statistical significance (p = 0.001). LPSexposed mice had a significantly increased caspase activity in bone marrow compared to placebo mice (p=0.03), and morphine significantly increased caspase activity (p=0.01).
Synergistic effects of morphine and LPS on caspase activity in tissues
A critical question that we set out to answer was, does an immune activating signal such as LPS act in concert with morphine in the induction of caspases at the tissue level? To answer this question, spleen, thymus, central nervous system (CNS), and liver tissues were immediately removed from the different treatment groups following in vivo exposure to the FLIVO caspase probe. These frozen tissues were sectioned and analyzed by fluorescence microscopy. In the spleen, thymus, and liver, LPS exposure was found to induce caspase activity as detected by fluorescence microscopy ( Table 1) . The co-administration of morphine and LPS significantly increased percentages of cells with increased levels of caspase activity in the spleen (p=0.01), thymus (p=0.01), and liver tissue (p=0.02) when compared to mice treated with LPS only. There was no significant increase of caspase activity in the CNS. Morphine exposure alone did not significantly induce caspase activity compared to placebo (Table 1) . Synergistic effects of morphine are morphine receptor-mediated
To address the question of the specificity of morphine's effect in vivo on caspase activity, we measured and compared caspase activity in splenocytes from μ-opioid receptor knockout (MORKO) mice and wild-type mice. Mice were administered morphine, LPS, or morphine + LPS as described in the "Materials and method" section, and saline was used as a control. To illustrate that morphine effects were mediated through μ-opioid receptor, splenocytes isolated from MORKO and wild-type mice treated with morphine + LPS treatment were overlaid in a histogram (Fig. 3a) . Percentages of cells with increased levels of caspase activity were imported into a dot plot (Fig. 3b) and analyzed by ANOVA for statistical significance (p=0.002). Morphine significantly enhanced LPSinduced caspase activity in wild-type mice. In comparison, morphine administration had little to no effect on LPSinduced caspase activity in μ-opioid receptor knockout mice. In addition, caspase activity was significantly reduced in MORKO mice treated with morphine and LPS (p=0.01) when compared to wild-type mice. Morphine alone did not significantly induce caspase activity in either wild-type or MORKO mice.
Discussion
Morphine is one of the mostly widely prescribed analgesic opioids used to treat pain. Opioid drugs have consistently proven useful for managing chronic cancer pain and are classified by the World Health Organization as the second step in the analgesic ladder for pharmacotherapeutic treatment of long-term pain (Portenoy and Lesage 1999; Radbranch et al. 1996) . Unfortunately, high dosages of morphine have been associated with varying levels of adverse cytolytic effects (Nelson et al. 2000) . Currently, studies have alluded to the fact that morphine administration induces caspase; however, other studies failed to show a significant increase in caspase due to morphine alone. The study presented is the first to use an in vivo caspase detection assay to study the effects morphine has on the induction of caspase activity. Our novel method of detecting in vivo caspase activity has allowed us to conclude that acute morphine treatment alone has minimal effect on the up-regulation of caspase activity. However, co-administration of both LPS and morphine significantly enhanced caspase activity in all cell and tissue types. By injecting the caspase detection probe directly into the animals, generating false positives due to sample manipulation was avoided. By reducing background levels, a more accurate measurement of caspase activity associated with morphine and morphine + LPS was obtained. Mouse splenocytes and bone marrow were analyzed along with tissues derived from the thymus, CNS, spleen, and liver, using the unique in vivo caspase detection methodology. It was determined that morphine alone did not significantly up-regulate caspase activity in any of the tissues. However, morphine administration in combination with LPS administration again induced a highly significant increase of caspase activity in multiple tissues.
Acute and chronic morphine treatments have been associated with oxidative stress leading to the induction of apoptosis in various cell types, including cells of the immune system (Di Francesco et al. 1998) , kidneys (Patel et al. 2003) , epithelial cells (Macchia et al. 1999) , CNS (Goudas et al. 1999) , and liver (Payabvash et al. 2006) . It is also well documented that the immune-activating signal, LPS, induces caspase activity. This pro-inflammatory mediator can activate extrinsic (caspase 8) apoptotic pathways using cell membrane-associated signal transduction mechanisms such as TLR-4 and TNFα. Intraperitoneal LPS Fig. 3 The increase in morphine apoptosis is mu-receptor-mediated. To determine whether the increase in apoptosis is mu-receptormediated, mu-knockout and wild-type mice were compared for the induction of apoptosis following LPS administration. Mu-knockout and wild-type mice were administered morphine + LPS. Placebo was administered in mu-knockout for a negative control. a Using CellquestPro, a histogram of the various groups was overlaid to determine whether if increased apoptosis is morphine-mediated. Plots are representative of group (n=8). b Percentages derived from CellquestPro were plotted in a bar graph. A statistically significant change was determined by p<0.05 injection is often used as a model system for simulating the gram-negative, endotoxigenic, and bacterial sepsis state. Previous studies have concluded that morphine augments immune-mediated effects of LPS in mouse thymus and macrophage cells (Roy et al. 1999) , mouse leukocytes (Ocasio et al. 2004) , and human and rat vascular endothelial cells (Liu et al. 2004) . Prior chronic morphine treatment leads to an increase in LPS-induced septic shock associated with an elevation in the inflammatory cytokines TNFα, IL-1β, and IL-6, which may be a result from activated caspases Ghayur et al. 1997; Ocasio et al. 2004 ). Based upon this previously documented synergism, it was hypothesized that morphine would significantly increase LPS-induced caspase activity within a mouse morphine treatment model, providing a clinically significant model system for demonstrating the utility and assay sensitivity of an in vivo caspase detection assay format. The results of this study corroborate the initial hypothesis that morphine administration synergizes with LPS increasing caspase activity. In mice treated with morphine and LPS, there was a markedly increased amount of caspase activity detected in the spleen, liver, and thymus. There was no significant increase of caspase activity in the CNS following morphine administration.
An abundance of studies have reported that the induction of the caspase cascade is via morphine's interaction with morphine receptors. Morphine receptors are located on a number of different cell types including neurons and microglia (Hu et al. 2002) , lymphocytes , endothelial cells (Liu et al. 2004) , and cells in spleen, heart, and lung tissue (Yin et al. 1999) . To address the question of whether morphine-induced caspase activity is mediated by opioid receptors, we measured caspase induction in mu-knockout mice following morphine exposure. A clear decrease in the number of cells demonstrating caspase activity in mu-knockout mice compared to wild-type animals was found, suggesting that morphine modulates caspase induction via the mu-receptor. Correspondingly, the intensity of caspase activity in mu-knockout mice was due to LPS administration alone.
Morphine-induced apoptosis has remained controversial for many years. Studies have demonstrated that morphine administration induces apoptosis; however, other studies failed to detect a significant increase in apoptosis following morphine administration. Apoptosis is an important mechanism involved in the removal of infected or dying cells. False-positive results derived from manipulation of tissues make it difficult to accurately interpret experimental results. Our present study is the first to use in vivo caspase detection techniques to monitor the positive correlation between morphine exposure and caspase activation. Using our method of in vivo caspase activity detection, it was found that morphine treatment alone has minimal effect on the induction of caspases. However, co-administration of both LPS and morphine significantly enhanced caspase activity in all cell and tissue types.
We concede that the mere detection of increased overall intracellular caspase activity does not automatically guarantee that an apoptotic event will ensue. However, when considered in conjunction with the vast amount of research linking morphine exposure to up-regulation of the FAS extrinsic apoptosis induction pathway, it is not unreasonable to assume that a majority of the caspase-positive cells are truly undergoing apoptosis and not autophagy or a caspase 1 housekeeping process. Ideally, it would be advantageous to specifically verify the presence of caspase 3 activity in these caspase-positive cells, to truly validate the presence of an apoptotic end point. However, the existence of a specific caspase, for a particular 3 or 4 amino acid targeting sequence relationship, simply does not exist in nature. Our process does accomplish the goal of in vivo labeling and detection of caspase activity associated with a particular physiological event.
